Mcia Inc Novartis Ag Transaction History

Mcia Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 09, 2021	SELL	$85.24 - $94.15 $775,257 - $856,294	-9,095 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$83.5 - $98.47 $424,180 - $500,227	5,080 Added 126.53%	9,095 $788,000
Q4 2020 Jan 13, 2021	BUY	$78.07 - $94.43 $313,451 - $379,136	4,015 New	4,015 $379,000
Q4 2020 Jan 12, 2021	SELL	$78.07 - $94.43 $320,789 - $388,012	-4,109 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$82.14 - $91.0 $337,513 - $373,919	4,109 New	4,109 $363,000
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $13,019 - $13,975	-180 Closed	0 $0
Q3 2017 Nov 01, 2017	SELL	$74.14 - $77.27 $2,224 - $2,318	-30 Reduced 14.29%	180 $15,000
Q2 2017 Aug 16, 2017	BUY	N/A	210	210 $18,000

1,426

138M

1.48M

1.54M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $245B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Mcia Inc, based on Form 13F filings with the SEC.

Stay updated on Mcia Inc with notifications on news.